Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
THE OFF-LABEL USE OF PSYCHOTROPIC MEDICINES IN PAEDIATRICS WITH MAJOR DEPRESSION
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Poster
- By: TANANA, Laila (University of Sydney, School of Pharmacy, Australia)
- Co-author(s): Laila Tanana: School of Pharmacy, University of Sydney, Australia
Asam Latif: School of Health Sciences, University of Nottingham, United Kingdom
Prasad S Nishtala: Department of Pharmacy & Pharmacology, University of Bath, United Kingdom
Timothy F Chen: School of Pharmacy, University of Sydney, Australia
BackgroundThere is limited published research about the off-label use (OLU) of psychotropic medicines in paediatrics.
MethodsThe psychotropic medicines recommended by the Maudsley Guidelines for P-MD (≤18 years), were compared against the regulatory-approved SmPC (or equivalent) documents from Australia (AU), New Zealand (NZ), the United Kingdom.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019